Bortezomib therapy in patients with relapsed/refractory acquired thrombotic thrombocytopenic purpura
Crossref DOI link: https://doi.org/10.1007/s00277-016-2804-x
Published Online: 2016-09-03
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Eskazan, Ahmet Emre http://orcid.org/0000-0001-9568-0894
License valid from 2016-09-03